{
    "code": "02024998",
    "time": "2015-06-22 01:43:38",
    "許可證字號": "衛署藥輸字第024998號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/03\/24",
    "發證日期": "98\/03\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202499800",
    "中文品名": "大塚安立復口溶錠 15 毫克",
    "英文品名": "OTSUKA ABILIFY DISCMELT 15mg Orally Disintegrating Tablets",
    "適應症": "成人和青少年(13至17歲)的精神分裂症。成人和兒童(10至17歲)的雙極性疾患之躁症發作及混合型發作，可單獨使用或做為鋰鹽或Valproate的輔助治療。第一型雙極性疾患維持治療之鋰鹽或valproate的輔助治療。重鬱症之輔助治療。兒童（6至17歲）的自閉性疾患伴隨之急躁易怒。",
    "劑型": "199口溶錠",
    "包裝": "2~1000錠鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "ARIPIPRAZOLE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1403301100  台灣大塚製藥股份有限公司",
    "申請商地址": "台北市中山區復興北路378號11樓",
    "主製造廠": {
        "製造廠名稱": "F370013100  BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY",
        "製造廠廠址": "STATE ROAD #3, KM. 77.5, HUMACAO, PUERTO RICO 00791",
        "製造廠公司地址": "",
        "製造廠國別": "PUERTO RICO",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200095400",
            "成分名稱": "ARIPIPRAZOLE",
            "含量描述": "",
            "含量": "15.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 大塚_安立復口溶錠-(IIO0104)_66x52cm_F-103-11-18.pdf 大塚_安立復口溶錠-(IIO0104)_66x52cm_B-103-11-18.pdf 大塚安立復口溶錠_P___20110712.1.jpg 020249980001___20100826.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02024998&Seq=004&Type=9"
        }
    ]
}